Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

Abstract Aims Prior studies have not fully characterized the haemodynamic effects of the angiotensin receptor‐neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF–PH). The aim of the Treatment of PH With Angiotensin II R...

Full description

Bibliographic Details
Main Authors: Pau Codina, Mar Domingo, Elena Barceló, Paloma Gastelurrutia, Daniel Casquete, Joan Vila, Omar Abdul‐Jawad Altisent, Giosafat Spitaleri, Germán Cediel, Evelyn Santiago‐Vacas, Elisabet Zamora, María Ruiz‐Cueto, Javier Santesmases, Rafael de laEspriella, Domingo A. Pascual‐Figal, Julio Nuñez, Josep Lupón, Antoni Bayes‐Genis
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:ESC Heart Failure
Subjects:
Heart failure
Preserved LVEF
Pulmonary hypertension
Pulmonary artery pressure
ARNI
Online Access:https://doi.org/10.1002/ehf2.13952

Internet

https://doi.org/10.1002/ehf2.13952

Similar Items